InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Popovits Kimberly J, Director. Director active across 5 companies, notably 10x Genomics, Inc.. Cumulatively, 15 filings have been recorded. Breakdown: 0 buy · 1 sell. Activity tracked since 11 June 2021. The latest transaction was disclosed on 4 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Popovits Kimberly J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
8,829 shares0Class A Common StockSEC:0001610717-26-000193:0
6,725 sharesCommon StockSEC:0001193125-26-118745:0
45,748 shares@ US$10.36100.0% of flowClass A Ordinary ShareSEC:0001415889-25-020866:0
9,994 shares0Common StockSEC:0000950170-25-086888:0
15,357 shares0Class A Common StockSEC:0001610717-25-000169:0
3,173 sharesClass A Ordinary ShareSEC:0001415889-25-015788:0
6,387 shares0Common StockSEC:0000950170-25-002084:0
8,649 shares0Class A Common StockSEC:0001610717-24-000328:0
4,373 sharesClass A Common ShareSEC:0001415889-24-015997:0
5,000 sharesClass A Common ShareSEC:0001415889-23-010561:0
1,865 shares0Class A Common StockSEC:0001610717-23-000174:0
2,120 shares0Class A Common StockSEC:0001567619-22-013122:0
625 shares0Class A Common StockSEC:0001209191-21-040690:0
5,000 sharesCommon StockSEC:0001209191-16-091466:0
5,000 sharesCommon StockSEC:0001209191-16-091466:1
15 of 15 declarations
About Popovits Kimberly J
Popovits Kimberly J is Administrateur and has 15 filings in total. In the recent sample covered here, buy and sell amounts are 0 and 0 EUR, over the period from 2016-01-14 to 2026-06-08. The companies mentioned in the filings include 10x Genomics, Inc., Exact Sciences CORP, Kiniksa Pharmaceuticals International, plc, Kiniksa Pharmaceuticals, Ltd. and GENOMIC HEALTH INC, with an attribution filing and one top_filing amount of 414677.1834525084 EUR on 2025-08-01 for Kiniksa Pharmaceuticals International, plc.
